Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. logo

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (600332)

Market Closed
10 Aug, 06:57
SSE SSE
¥
21. 59
+0.09
+0.4186%
¥
41.05B Market Cap
8.23 P/E Ratio
1.6% Div Yield
12.18M Volume
0 Eps
¥ 21.5
Previous Close
Add Transaction
Day Range
21.49 21.86
Year Range
19.3 27.85
Want to track 600332 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600332 closed today higher at ¥21.59, an increase of 0.4186% from yesterday's close, completing a monthly increase of 7.8422% or ¥1.57. Over the past 12 months, 600332 stock lost -16.1228%.
600332 pays dividends to its shareholders, with the most recent payment made on Jun 16, 2026. The next estimated payment will be in In 4 months on Dec 16, 2026 for a total of ¥0.45.
The last earnings report, released on Apr 29, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.1467%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on SSE (CNY).

600332 Chart

People also search for

SAIC Motor Corporation Limited
¥ 10.48
+0.2871%
Seres Group Co., Ltd.
¥ 56.03
-1.3904%
Great Wall Motor Co., Ltd.
¥ 15.69
+0.706%
Fuyao Glass Industry Group Co., Ltd.
¥ 56.59
+2.148%
China Tourism Group Duty Free Corporation Limited
¥ 56.24
+0.7524%

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (600332) FAQ

What is the stock price today?

The current price is ¥21.59.

On which exchange is it traded?

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600332.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.6%.

What is its market cap?

As of today, the market cap is 41.05B.

Has Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. ever had a stock split?

No, there has never been a stock split.

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Hong Li CEO
SSE Exchange
CNE000001733 ISIN
CN Country
27,057 Employees
16 Jun 2026 Last Dividend
- Last Split
30 Oct 1997 IPO Date

Overview

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a comprehensive entity focusing on the pharmaceutical sector. Engaged in the research, development, manufacture, and distribution of a wide array of products, comprising Chinese patent medicines, Western medicines, chemical raw materials, as well as natural and biological medicines. The company's operations are spread out on both a domestic level within the People's Republic of China and an international scale. It functions across four primary segments: Great Southern Medicine, Great Commerce, Great Health, and Great Medical Care, providing a broad spectrum of healthcare solutions. Originally operating under the name Guangzhou Pharmaceutical Company Limited until August 2013, it underwent a rebranding to its current identity. Since its establishment in 1997, the company has been headquartered in Guangzhou, China. Its business operations are not just limited to pharmaceuticals; Guangzhou Baiyunshan also engages in the health industry and offers diversified services including advertising and business agency services.

Products and Services

  • Pharmaceuticals
  • Includes both Chinese patent medicines and Western medicines. The company excels in providing effective drug solutions drawn from extensive research and development activities, along with manufacturing capabilities that adhere to stringent quality standards.

  • Chemical Raw Materials and Intermediates
  • Focused on the production of chemical raw materials and their intermediates, which are crucial components in the pharmaceutical manufacturing process, helping in the creation of a variety of medicinal drugs.

  • Natural and Biological Medicines
  • Dedicated to the exploration and development of treatments derived from natural sources and biotechnology, offering innovative health solutions in line with modern medical science advancements.

  • Medical Devices
  • Engages in the sale, including both import and export, of medical devices, providing healthcare institutions and professionals with essential tools for medical procedures and patient care.

  • Consumer Health Products
  • This category includes a range of health-focused beverages, food, healthcare products, and more. The company invests in producing and selling pre-packaged food, dairy products, herbal teas, tablets, capsules, lozenges, and Guiling jellies, projecting a holistic approach to health and wellness.

  • Retail Chain Pharmacy Stores
  • Manages a network of retail chain pharmacy stores and retail outlets, which are instrumental in making their pharmaceutical and healthcare products accessible to a wide array of consumers.

  • Health Industry Investment
  • Invests in the broader health industry encompassing medical services, health management, healthcare, elderly care, and related fields, aiming to build an integrated ecosystem for health and wellness services.

  • Business and Advertising Agency Services
  • Offers specialized services in business and advertising, aiding in the promotion and operational efficiency of healthcare products and services across various platforms.

Contact Information

Address: 45 Sha Mian North Street
Phone: 86 20 6628 1218